Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Biotech Acquisition Company/ 10-K

Annual Report · 10-K

Biotech Acquisition Company

Annual Report

Filed Mar 8, 2022Accepted Mar 7, 2022, 4:53 PM ESTCIK 1825413Accession 0001213900-22-010984
View company →Permanent SEC source ↗
Share

Company context

Historical securities (3)
BIOTOTC · EQUITY · Historical · closed Feb 2, 2023BIOTUNASDAQ · UNIT · Historical · closed Feb 2, 2023BIOTWNASDAQ · WARRANT · Historical · closed Feb 2, 2023

Recent company filings

  1. 15-12G filingFeb 14, 2023
  2. SC 13G/A filingFeb 14, 2023
  3. SC 13G/A filingFeb 13, 2023
  4. 25-NSE filingFeb 2, 2023
  5. 8-K filingFeb 2, 2023

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗